The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC

Thrombosis Research

Volumn 120, Issue 1, 2007, Pages 71-79

  Holzer, Gregor ^a   Esterbauer, Harald ^a   Kronke, Gerhard ^a   Exner, Markus ^a   Kopp, Christoph W ^a   Leitinger, Norbert ^a   Wagner, Oswald ^a   Gmeiner, Bernhard M K ^a   Kapiotis, Stylianos ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherothrombosis; Coagulation; Endothelium; Flavonoids; Inflammation; Lipoproteins

Indexed keywords

1 PALMITOYL 2 ARACHIDONOYLGLYCERO 3 PHOSPHORYLCHOLINE; ANTIESTROGEN; ESTROGEN RECEPTOR; GENISTIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PROTEIN TYROSINE KINASE INHIBITOR; THROMBOPLASTIN; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; AORTA; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD CLOTTING; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; SOYBEAN; UMBILICAL VEIN; WESTERN BLOTTING;

ANTICOAGULANTS; ATHEROSCLEROSIS; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; GENISTEIN; HUMANS; PHOSPHATIDYLCHOLINES; THROMBOPLASTIN;

EID: 34247112438     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.07.007     Document Type: Article

References (42)

1. Edgington T.S., Mackman N., Brand K., and Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 661 (1991) 67-79
2. Colucci M., Balconi G., Lorenzet R., Pietra A., Locati D., Donati M.B., et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 716 (1983) 1893-1896
3. Carson S.D., Johnson D.R., and Tracy S.M. Tissue factor and the extrinsic pathway of coagulation during infection and vascular inflammation. Eur Heart J 14 Suppl K (1993) 98-104
4. Semeraro N., and Colucci M. Tissue factor in health and disease. Thromb Haemost 781 (1997) 759-764
5. Nemerson Y. Tissue factor and hemostasis. Blood 711 (1988) 1-8
6. Toschi V., Gallo R., Lettino M., Fallon J.T., Gertz S.D., Fernandez-Ortiz A., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 953 (1997) 594-599
7. Berliner J.A., Subbanagounder G., Leitinger N., Watson A.D., and Vora D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc Med 113-4 (2001) 142-147
8. Watson A.D., Leitinger N., Navab M., Faull K.F., Horkko S., Witztum J.L., et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 27221 (1997) 13597-13607
9. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 966 (1995) 2882-2891
10. Bochkov V.N., Mechtcheriakova D., Lucerna M., Huber J., Malli R., Graier W.F., et al. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. Blood 991 (2002) 199-206
11. Anderson J.W., Johnstone B.M., and Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 3335 (1995) 276-282
12. Erdman Jr. J.W. AHA Science Advisory: Soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 10220 (2000) 2555-2559
13. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., and Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 1137 (2006) 1034-1044
14. Zand R.S., Jenkins D.J., and Diamandis E.P. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 621 (2000) 35-49
15. Cos P., De Bruyne T., Apers S., Vanden Berghe D., Pieters L., and Vlietinck A.J. Phytoestrogens: recent developments. Planta Med 697 (2003) 589-599
16. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 26212 (1987) 5592-5595
17. Rathel T.R., Leikert J.F., Vollmar A.M., and Dirsch V.M. The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro. Br J Pharmacol 1443 (2005) 394-399
18. Liu D., Homan L.L., and Dillon J.S. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5′-monophosphate-dependent mechanism. Endocrinology 14512 (2004) 5532-5539
19. Deodato B., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Minutoli L., et al. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol 1288 (1999) 1683-1690
20. Tikkanen M.J., and Adlercreutz H. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?. Biochem Pharmacol 601 (2000) 1-5
21. Nestel P.J., Yamashita T., Sasahara T., Pomeroy S., Dart A., Komesaroff P., et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1712 (1997) 3392-3398
22. Squadrito F., Altavilla D., Morabito N., Crisafulli A., D'Anna R., Corrado F., et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 1632 (2002) 339-347
23. Kapiotis S., Hermann M., Held I., Seelos C., Ehringer H., and Gmeiner B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1711 (1997) 2868-2874
24. Fotsis T., Pepper M.S., Montesano R., Aktas E., Breit S., Schweigerer L., et al. Phytoestrogens and inhibition of angiogenesis. Bailliere's Clin Endocrinol Metab 124 (1998) 649-666
25. Shimokado K., Yokota T., Kosaka C., Zen K., Sasaguri T., Masuda J., et al. Protein tyrosine kinase inhibitors inhibit both proliferation and chemotaxis of vascular smooth muscle cells. Ann N Y Acad Sci 748 (1995) 171-175
26. Guerrero J.A., Lozano M.L., Castillo J., Benavente-Garcia O., Vicente V., and Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost 32 (2005) 369-376
27. Bucki R., Pastore J.J., Giraud F., Sulpice J.C., and Janmey P.A. Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis. J Thromb Haemost 18 (2003) 1820-1828
28. Jaffe E.A., Grulich J., Weksler B.B., Hampel G., and Watanabe K. Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J Biol Chem 26218 (1987) 8557-8565
29. Kapiotis S., Besemer J., Bevec D., Valent P., Bettelheim P., Lechner K., et al. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 782 (1991) 410-415
30. Mayrand P.E., Robertson J., Ziegle J., Hoff L.B., McBride L.J., Chamberlain J.S., et al. Automated genetic analysis. Ann Biol Clin (Paris) 494 (1991) 224-230
31. Kadl A., Huber J., Gruber F., Bochkov V.N., Binder B.R., and Leitinger N. Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vasc Pharmacol 384 (2002) 219-227
32. Mukherjee T.K., Nathan L., Dinh H., Reddy S.T., and Chaudhuri G. 17-Epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J Biol Chem 27814 (2003) 11746-11752
33. Sakamoto T., Ishibashi T., Sakamoto N., Sugimoto K., Egashira K., Ohkawara H., et al. Endogenous NO blockade enhances tissue factor expression via increased Ca2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Arterioscler Thromb Vasc Biol 259 (2005) 2005-2011
34. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 1135 (2006) 722-731
35. McNicol A. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukot Essent Fat Acids 485 (1993) 379-384
36. Asahi M., Yanagi S., Ohta S., Inazu T., Sakai K., Takeuchi F., et al. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. FEBS Lett 3091 (1992) 10-14
37. Setchell K.D., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T., et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 1314 Suppl (2001) 1362S-1375S
38. Wang W., Zhu G.J., and Zu S.Y. Effects of 17beta-estradiol and phytoestrogen alpha-zearalanol on tissue factor in plasma of ovariectomized rats and HUVECs. Chin J Physiol 472 (2004) 67-72
39. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 13910 (1998) 4252-4263
40. Yang Y., and Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 10118 (2000) 2144-2148
41. Perez-Ruiz A., Montes R., Velasco F., Lopez-Pedrera C., Antonio P.J., Orbe J., et al. Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells. Thromb Haemost 886 (2002) 1060-1065
42. Xu H.S., Duan J., Dai S., Wu Y., Sun R., and Ren J. Phytoestrogen alpha-zearalanol antagonizes oxidized LDL-induced inhibition of nitric oxide production and stimulation of endothelin-1 release in human umbilical vein endothelial cells. Endocrine 253 (2004) 235-245